What 4 Analyst Ratings Have To Say About Universal Health Servs
Portfolio Pulse from Benzinga Insights
Within the last quarter, Universal Health Servs (NYSE:UHS) received 3 indifferent and 1 somewhat bearish analyst ratings. The average price target is $143.25, which is a 3.86% decrease from the previous target of $149.00, but still implies an upside from the current price of $140.89. Analysts' ratings are based on predictions of a company's future earnings and revenue, and are updated quarterly or after major company events.
December 11, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Universal Health Servs received a lukewarm response from analysts with no bullish ratings, 3 indifferent, and 1 somewhat bearish. The average price target suggests a modest upside potential from the current stock price.
The analyst ratings for UHS are predominantly neutral with a slight negative bias, which suggests that the stock may not see significant movement. The average price target is slightly above the current price, indicating potential for modest growth, but the decrease in the target from $149.00 to $143.25 may temper investor expectations. The ratings are a mix of recent assessments and may already be factored into the current stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100